Combined prognostic value of age at onset and socioeconomic status for long-term survival in metastatic breast cancer
Abstract
We investigated the combined long-term prognostic value of age at onset and socioeconomic status (SES) on breast cancer overall survival (OS) and metastasis-free survival (MFS) in a cohort of women with metastatic breast cancer. Age at onset was defined as the age at primary diagnosis, with a 40-year cutoff to distinguish early- and late-onset. We estimated individual SES from patients’ reported household income, occupational categories, and education levels. We estimated Kaplan‒Meier survival curves and performed regression analyses using the Cox model, including an interaction term of age at onset and SES. In 109 women included in the study, those with early-onset breast cancer had a non-significantly higher mortality rate than those with late-onset breast cancer (rate difference 0.03/PY). The hazard of metastasis was significantly lower for the medium SES (HR 0.37, 95% CI 0.19–0.69) and the high SES (HR 0.34, 95% CI 0.18–0.63) than for the low SES group. Compared to late-onset, early-onset cases had no difference in OS or MFS within the first 10 and 2 years following primary diagnosis, respectively. However, early-onset cases had a worse prognosis thereafter. Similarly, high SES was associated with better survival but only after 7.5 and 3 years following primary diagnosis for OS and MFS, respectively. We found a significant effect modification: higher SES mitigates the effect of early-onset status while it offered minimal survival benefit when age at onset was over 65 years. The combination of age at onset and SES may provide long-term prognostic information. As breast cancer survival has improved in recent decades, addressing SES-related social determinants in clinical settings has become increasingly important for optimizing long-term outcomes.
Related
- Receptor Status Changes, HER2-Low Discordance, and TNBC Transformation in Metastatic Breast Cancer: Prognostic Significance and Impact on Survival Outcomes
- Development and internal validation of a prognostic model for cancer-specific survival in elderly patients with metastatic non-small cell lung cancer: a SEER-based study
- The Prognostic Role of HPV Status Based on the Analysis of Outcomes of Combined Treatment of Oral Cavity and Oropharyngeal Cancers
- Combined Use of Clinician Prediction of Survival and the Palliative Prognostic Index for Short‐Term Mortality Screening in Advanced Cancer Patients in an Acute Care Hospital
- Baseline 25-hydroxyvitamin D and progression-free survival in de novo metastatic hormone-sensitive prostate cancer: prognostic model development and external validation.
BibTeX
@article{zhou2026combined,
title = {{Combined prognostic value of age at onset and socioeconomic status for long-term survival in metastatic breast cancer}},
author = {Ke Zhou and Germán Cano-Sancho and Caroline Goupille and Vincent Bessonneau and Eva Gorrochategui Matas and Christine Bobin-Dubigeon and Jean-Sébastien Frénel and Martine Bellanger},
journal = {Scientific Reports},
year = {2026},
month = sep,
doi = {10.1038/s41598-026-69757-z},
url = {https://hal.science/hal-05750205v1},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Combined prognostic value of age at onset and socioeconomic status for long-term survival in metastatic breast cancer
AU - Ke Zhou
AU - Germán Cano-Sancho
AU - Caroline Goupille
AU - Vincent Bessonneau
AU - Eva Gorrochategui Matas
AU - Christine Bobin-Dubigeon
AU - Jean-Sébastien Frénel
AU - Martine Bellanger
PY - 2026
DA - 2026/09/15
JO - Scientific Reports
DO - 10.1038/s41598-026-69757-z
UR - https://hal.science/hal-05750205v1
AB - We investigated the combined long-term prognostic value of age at onset and socioeconomic status (SES) on breast cancer overall survival (OS) and metastasis-free survival (MFS) in a cohort of women with metastatic breast cancer. Age at onset was defined as the age at primary diagnosis, with a 40-year cutoff to distinguish early- and late-onset. We estimated individual SES from patients’ reported household income, occupational categories, and education levels. We estimated Kaplan‒Meier survival curves and performed regression analyses using the Cox model, including an interaction term of age at onset and SES. In 109 women included in the study, those with early-onset breast cancer had a non-significantly higher mortality rate than those with late-onset breast cancer (rate difference 0.03/PY). The hazard of metastasis was significantly lower for the medium SES (HR 0.37, 95% CI 0.19–0.69) and the high SES (HR 0.34, 95% CI 0.18–0.63) than for the low SES group. Compared to late-onset, early-onset cases had no difference in OS or MFS within the first 10 and 2 years following primary diagnosis, respectively. However, early-onset cases had a worse prognosis thereafter. Similarly, high SES was associated with better survival but only after 7.5 and 3 years following primary diagnosis for OS and MFS, respectively. We found a significant effect modification: higher SES mitigates the effect of early-onset status while it offered minimal survival benefit when age at onset was over 65 years. The combination of age at onset and SES may provide long-term prognostic information. As breast cancer survival has improved in recent decades, addressing SES-related social determinants in clinical settings has become increasingly important for optimizing long-term outcomes.
SN - 2045-2322
ER -